Our adjusted expense ratio was 17.5%, a 10 basis point improvement over the third quarter of 2016, driven primarily by the suspension of the health insurer fee in 2017 and the continued execution of our expense management initiatives, partially offset by the targeted investment spending on growth initiatives discussed on prior earnings calls this year